文献速递肾移植

低温机械灌注减轻肾移植延长冷缺血时间的不利影响

Hypothermic Perfusion Mitigates Extended Cold Ischemia Time in Kidney Transplantation.
PubMed 文献 · Clin J Am Soc Nephrol · 2025-09-19

该研究基于美国器官共享网络2005至2022年120438例成人首次单肾移植数据,比较静态冷储存与低温机械灌注对不同冷缺血时间结局的影响。结果显示,冷缺血≤36小时时低温机械灌注不增加死亡删失移植失败,并降低延迟移植物功能;超过36小时后灌注不再影响结局。

要点

  • 冷缺血≤36小时的肾脏,低温机械灌注不增加死亡删失移植失败。
  • 低温机械灌注在各冷缺血时间水平均降低延迟移植物功能发生率。
  • 冷缺血超过36小时后,无论储存方式如何,死亡删失移植失败均升高。

核心结论

  • 低温机械灌注是降低延长冷缺血时间负面效应的有效策略,可在不损害长期移植物结局的前提下为移植团队优化供受者物流提供更大灵活性。

研究设计与样本

  • 回顾性队列研究,分析美国器官共享网络数据库2005至2022年成人首次单肾移植受者,共120438例移植物。
  • 构建多变量模型分析死亡删失移植失败、非删失移植失败、延迟移植物功能和患者死亡,并校正供者、受者和移植因素。
  • 以冷缺血时间≤12小时的静态冷储存肾脏作为各模型的参照组。

主要发现

  • 120438例移植物中,63%采用静态冷储存,37%采用低温机械灌注。
  • 随着冷缺血时间增加,死亡删失移植失败呈剂量依赖性升高。
  • 低温机械灌注≤24小时的肾脏死亡删失移植失败低于参照组(静态冷储存≤12小时)。
  • 低温机械灌注24至36小时的肾脏死亡删失移植失败与参照组无差异。
  • 冷缺血超过36小时后,所有肾脏无论储存方式如何死亡删失移植失败均更高;低温机械灌注在各冷缺血时间水平均降低延迟移植物功能发生率。

临床怎么用

  • 对于冷缺血时间不超过36小时的肾脏,可考虑使用低温机械灌注以降低延迟移植物功能并优化供受者物流。
  • 冷缺血时间超过36小时时,低温机械灌注不再改善结局,应优先缩短冷缺血时间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Compared with ≤ 12 hours of static cold storage, hypothermic machine perfusion up to 36 hours did not increase death-censored graft failure. Hypothermic machine perfusion reduced delayed graft function for kidneys with ≤36 hours of cold ischemia time. When cold ischemia time exceeded 36 hours, hypothermic machine perfusion no longer affected outcomes. BACKGROUND: Extended cold ischemia time (CIT) is associated with higher incidences of delayed graft function (DGF) and graft failure. Kidneys on hypothermic machine perfusion (HMP) perform better than comparable kidneys in static cold storage (SCS). This study aimed to determine whether hypothermic perfusion was associated with lowering the deleterious effects of extended CIT. METHODS: Data from the United Network of Organ Sharing database were examined to identify adult first-time, kidney-only recipients from 2005 to 2022. Multivariable models for death-censored graft failure (dcGF), uncensored graft failure, DGF, and patient mortality were constructed and adjusted for donor, recipient, and transplant factors. Kidneys with ≤12 hours SCS, an accepted standard for optimal transplantation, served as the reference group for each model. RESULTS: Among 120,438 allografts, 63% were in SCS and 37% were preserved with hypothermic perfusion. DcGF was higher in a dose-dependent fashion as CIT increased. Kidneys on HMP for ≤24 hours had less dcGF than reference (≤12 hours in SCS) kidneys. Perfusion for 24–36 hours did not differ from reference. After 36 hours, all kidneys had higher dcGF, regardless of the storage method. HMP lowered the incidence of DGF at every level of CIT. CONCLUSIONS: HMP is an effective strategy for lowering the negative effect of prolonged CIT, providing transplant teams with greater flexibility to optimize donor and recipient logistics, without compromising long-term graft outcomes.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Perez-Gutierrez A, Cao J, Bachul P, et al. Hypothermic Perfusion Mitigates Extended Cold Ischemia Time in Kidney Transplantation. Clin J Am Soc Nephrol. 2025. PMID: 40971207. doi:10.2215/CJN.0000000848

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。